Search

Searching with a thematic focus on Trade Policy, Intellectual Property Rights in India

Showing 21-30 of 42 results

Pages

• Document

  A briefing paper for DFID: update on China and India and access to medicines

  DFID Health Resource Centre (HRC), 2005

  This paper, from the DFID Health Resource Centre, examines how Intellectual Property (IP) agreements impact upon the pharmaceutical sector in China and India, and how this in turn affects access to medicines.
• Document

  What has been achieved, what have been the constraints and what are the future priorities for pharmaceutical product-related R&D relevant to the reproductive health needs of developing countries?

  Commission on Intellectual Property Rights, Innovation and Public Health, 2005

  This paper examines the role of public and private sectors in the development of contraception and other pharmaceutical products. It also explores the obstacles to availability of these products in developing countries, as well as further research needs.
• Document

  Strengthening intellectual property rights globally: impact on India’s pharmaceutical exports

  Gujarat Institute of Development Research, India, 2004

  The emergence of a global intellectual property protection regime based on the trade-related intellectual property rights (TRIPS) agreement is intuitively likely to be good for the exports of developed countries which create new technologies, but not for those middle-income developing countries whose industries rely on the imitation of technologies.However, although empirical research has been
• Document

  AIDS In India: public health related aspects of industrial and intellectual property rights policies in a developing country

  Centre de Sciences Humaines, New Delhi, 2004

  By 2004, an estimated 40 million people world-wide are infected by the Acquired Immuno-Deficiency Syndrome (AIDS) or the Human Immuno-Deficiency Virus (HIV). The epidemic essentially affects developing countries (DCs), and India is no exception, with reported cases numbering around 4 million.
• Document

  Access to medicines in under-served markets: what are the implications of changes in intellectual property rights, trade and drug registration policy?

  Department for International Development Health Systems Resource Centre, 2004

  This research paper from the DFID Health Systems Resource Centre shows that the laws on Trade-Related Aspects of Intellectual Property (TRIPS) are having a negative effect on health systems in developing countries.The report brings together findings from seven studies commissioned by DFID on the public health implications of TRIPS for developing countries and the effect it has on access to drug
• Document

  Interest groups and patent reform in India

  Indira Gandhi Institute of Development Research, India, 2004

  Prior to 1998 India was one of the most vociferous opponents of revising its patent laws according to the World Trade Organization’s (WTO) Trade-Related Intellectual Property Rights (TRIPs) agreement.
• Document

  The effect of changing intellectual property on pharmaceutical industry prospects in India and China: considerations for access to medicines

  Department for International Development Health Systems Resource Centre, 2004

  This HSRC report explores the implications of changing Intellectual Property (IP) on access to medicines (ATM) in India and China by asking two key questions: how will the implementation of product patents affect the pharmaceutical industries in these countries; and what will happen to the supply of low-priced medicines domestically and internationally.
• Document

  The role of registers and databases in the protection of traditional knowledge: a comparative analysis

  Institute of Advanced Studies. United Nations University,, 2004

  There are various mechanisms which can be used to protect Traditional Knowledge (TK).
• Document

  Food security and intellectual property rights in developing countries

  International Environmental Law Research Centre, 2003

  This paper examines the implications of intellectual property rights (IPRs) on food security and the agricultural sector.
• Document

  Performance of BT cotton in India: data from the first commercial crop

  Gene Campaign, 2003

  This paper presents data on the field study of the first genetically modified crop to be cultivated in India.

Pages